Should we reestablish the lung cancer study group? Journal Article


Author: Rusch, V. W.
Article Title: Should we reestablish the lung cancer study group?
Abstract: The hallmark of the Lung Cancer Study Group (LCSG) was its multidisciplinary approach to cancer management, based on close collaboration among thoracic surgeons, medical oncologists, radiation oncologists, pathologists, biostatisticians, and data managers. Discontinuation of funding for the group dispersed a critical mass of thoracic oncologists and had serious adverse effects on clinical trials in early-stage thoracic malignancies, on translational research, and on oncologic education. The use of an intergroup mechanism for clinical trials has been partially successful in continuing the work started by the LCSG, but a sustained effort will be necessary to recreate the framework for clinical investigation provided by the group.
Keywords: lung cancer; cancer research; clinical research; medical specialist; health care financing; priority journal; article
Journal Title: Chest
Volume: 106
Issue: 6 Suppl.
ISSN: 0012-3692
Publisher: American College of Chest Physicians  
Date Published: 1994-12-01
Start Page: 408S
End Page: 410S
Language: English
DOI: 10.1378/chest.106.6_Supplement.408S
PROVIDER: scopus
PUBMED: 7988274
DOI/URL:
Notes: Export Date: 14 January 2019 -- Article -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Valerie W Rusch
    869 Rusch